Next Article in Journal
Clinical Relevance of CDH1 and CDH13 DNA-Methylation in Serum of Cervical Cancer Patients
Next Article in Special Issue
Molecular Mechanisms of Aging and Immune System Regulation in Drosophila
Previous Article in Journal
Occurrence of Aflatoxins in Selected Processed Foods from Pakistan
Previous Article in Special Issue
WIP Remodeling Actin behind the Scenes: How WIP Reshapes Immune and Other Functions
Open AccessReview

Role of Endoplasmic Reticulum Aminopeptidases in Health and Disease: from Infection to Cancer

1
Paediatric Haematology/Oncology Department, Bambino Gesù Children’s Hospital IRCCS, Piazza S. Onofrio 4, Rome 00165, Italy
2
University of Pavia, Corso Strada Nuova 65, Pavia I-27100, Italy
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2012, 13(7), 8338-8352; https://doi.org/10.3390/ijms13078338
Received: 1 June 2012 / Revised: 27 June 2012 / Accepted: 29 June 2012 / Published: 4 July 2012
(This article belongs to the Special Issue Advances in Molecular Immunology)
Endoplasmic reticulum (ER) aminopeptidases ERAP1 and ERAP2 (ERAPs) are essential for the maturation of a wide spectrum of proteins involved in various biological processes. In the ER, these enzymes work in concert to trim peptides for presentation on MHC class I molecules. Loss of ERAPs function substantially alters the repertoire of peptides presented by MHC class I molecules, critically affecting recognition of both NK and CD8+ T cells. In addition, these enzymes are involved in the modulation of inflammatory responses by promoting the shedding of several cytokine receptors, and in the regulation of both blood pressure and angiogenesis. Recent genome-wide association studies have identified common variants of ERAP1 and ERAP2 linked to several human diseases, ranging from viral infections to autoimmunity and cancer. More recently, inhibition of ER peptide trimming has been shown to play a key role in stimulating innate and adaptive anti-tumor immune responses, suggesting that inhibition of ERAPs might be exploited for the establishment of innovative therapeutic approaches against cancer. This review summarizes data currently available for ERAP enzymes in ER peptide trimming and in other immunological and non-immunological functions, paying attention to the emerging role played by these enzymes in human diseases. View Full-Text
Keywords: endoplasmic reticulum aminopeptidases; MHC class I; antigen processing; autoimmunity; viral infection; cancer; cancer immunotherapy endoplasmic reticulum aminopeptidases; MHC class I; antigen processing; autoimmunity; viral infection; cancer; cancer immunotherapy
Show Figures

Graphical abstract

MDPI and ACS Style

Cifaldi, L.; Romania, P.; Lorenzi, S.; Locatelli, F.; Fruci, D. Role of Endoplasmic Reticulum Aminopeptidases in Health and Disease: from Infection to Cancer. Int. J. Mol. Sci. 2012, 13, 8338-8352.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop